Receive the experimental combination of drugs (chemoradiation (Oxaliplatin and Capecitabine) + PD-1 inhibitor (Tislelizumab) for 3 cycles: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
2
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal cancer | 1 |
| Rectal Cancer Patients | 1 |
Recruiting trials involving Receive the experimental combination of drugs (chemoradiation (Oxaliplatin and Capecitabine) + PD-1 inhibitor (Tislelizumab) for 3 cycles
Common questions
How many recruiting trials involve Receive the experimental combination of drugs (chemoradiation (Oxaliplatin and Capecitabine) + PD-1 inhibitor (Tislelizumab) for 3 cycles?
1 recruiting trial across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.